Format

Send to

Choose Destination
PLoS One. 2018 Jul 10;13(7):e0200363. doi: 10.1371/journal.pone.0200363. eCollection 2018.

Prevalence of extraintestinal manifestations in Korean inflammatory bowel disease patients.

Author information

1
Medical Research Collaborating Center, Seoul National University Hospital, Seoul, Republic of Korea.
2
Department of Health Convergence, Ewha Womans University, Seoul, Republic of Korea.
3
Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
4
Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
5
Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
6
Medical Affairs, Janssen Korea, Seoul, Republic of Korea.
7
School of Medicine, Inha University, Incheon, Republic of Korea.
8
Department of Prevention and Management, Inha University Hospital, Incheon, Republic of Korea.

Abstract

BACKGROUND:

The prevalence of inflammatory bowel disease (IBD) in South Korea is increasing. Although extraintestinal manifestations (EIMs) are an important factor in the clinical outcomes of IBD patients, EIMs have not yet been investigated in Korea. Thus, we conducted a cross-sectional study to assess the prevalence of EIMs in Korean IBD patients.

METHODS:

The 2014 claims data from the National Health Insurance System (NHIS) of Korea were used. IBD patients were identified by codes for Crohn disease (CD) and ulcerative colitis (UC) in the NHIS registration system for rare or intractable diseases. International Classification of Diseases, Tenth Edition codes were used to identify EIM cases. To estimate the prevalence of EIMs in the general population of Korea, we used national sample data. Standardized prevalence ratios (SPRs) were calculated to compare the prevalence rates of EIMs among IBD patients to those among the general population of Korea.

RESULTS:

A total of 13,925 CD patients and 29,356 UC patients were identified. CD and UC patients were different in terms of demographics and utilization of medication. Among the 17 EIMs investigated, pyoderma gangrenosum, osteomalacia, Sweet syndrome, and scleritis were observed in very few patients. The SPRs were greater than 1 for all EIMs. Aphthous stomatitis, rheumatoid arthritis, and osteoporosis were highly prevalent in both CD and UC patients, but the SPRs of the EIMs were not high.

CONCLUSION:

The study confirmed that EIMs are more prevalent among IBD patients than among the general population of Korea. The prevalence of EIMs in IBD patients suggests the need for greater attention and effort in clinical practice.

PMID:
29990326
PMCID:
PMC6039042
DOI:
10.1371/journal.pone.0200363
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center